Use of Complementary and Integrative Medicine Among Patients With Glioblastoma Multiforme Seen at a Tertiary Care Center

Use of Complementary and Integrative Medicine Among Patients With Glioblastoma Multiforme Seen at a Tertiary Care Center

Background Glioblastoma multiforme (GBM) is among the most aggressive and lethal tumors, with a median survival of 12–15 months. Many patients use complementary and integrative medicine (CIM) therapies to supplement their cancer treatment. Objective To determine the prevalence of CIM use and identif...

Full description

Bibliographic Details
Main Authors: Amanda Munoz-Casabella MD, Dietlind L. Wahner-Roedler MD, Ivana T. Croghan PhD, Tanya M. Petterson MS, Debbie L. Fuehrer LPCC, Brent A. Bauer MD
Format: Article
Language:English
Published: SAGE Publishing 2022-02-01
Series:Global Advances in Health and Medicine
Online Access:https://doi.org/10.1177/2164957X221078543

Similar Items

Similar Items